Chiara Napoletano

16PUBLICATIONS
34CO-AUTHORS
Immunogenetics (incl. genetic immunology)Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersTumour immunology
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Mar 28, 2026
ASGR2 and CLEC12A as Prognostically Relevant C-Type Lectin Hubs in Glioblastoma.

Angelica Pace, Caterina Alfano, Luca D'Angelo

|Mar 28, 2026
Correlation Between Oxidative Stress and Immune Profiles During Immunotherapy in Metastatic Non-Oncogene-Addicted NSCLC Patients.

Mariangela Peruzzi, Lucrezia Tuosto, Alain Gelibter

|Feb 14, 2026
The immunological fitness of NSCLC patients drives the response to anti-PD1-based immunotherapy regardless of age.

Lucrezia Tuosto, Alain Gelibter, Lidia Strigari

|Sep 15, 2023
Targeting FGFRs by pemigatinib induces G1 phase cell cycle arrest, cellular stress and upregulation of tumor suppressor microRNAs.

Angelica Pace, Fabio Scirocchi, Chiara Napoletano

Pageof 3